Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Female Health Co (FHCO.O)

FHCO.O on Consolidated Issue listed on NASDAQ Capital Market

1.27USD
1 Jul 2016
Change (% chg)

$0.01 (+0.79%)
Prev Close
$1.26
Open
$1.27
Day's High
$1.30
Day's Low
$1.26
Volume
39,096
Avg. Vol
178,458
52-wk High
$2.75
52-wk Low
$1.16

Parrish, Overton 

Mr. Overton B. Parrish, Jr., serves as Chairman of the Board, Chief Executive Officer of The Female Health Company. Mr. Parrish, a founder, has served as the Chief Executive Officer of the Company since July 2015 and as the Chairman of the Board and a Director of the Company since 1987. Mr. Parrish previously served as the Chief Executive Officer of the Company from 1994 to January 2014, as acting President from May 2006 to January 2014, and as acting Chief Financial and Accounting Officer from February 1996 to March 1999. Mr. Parrish is a shareholder and has served as the President and as a Director of Phoenix Health Care of Illinois, Inc. (“Phoenix of Illinois”) since 1987. Phoenix of Illinois owns 233,501 shares of our Common Stock. Mr. Parrish also is Chairman and a Director of Abiant, Inc., a neuroimaging company focusing on assessing drug effects on the brain and developing diagnostic tests for the early detection of Alzheimers Disease and other brain disorders and monitoring the results of treatment, and a Director of Algasol Renewables, a technology company with proprietary technology to produce algae bimass for use in biofuels, cosmetics, pharmacuticals and other products. Mr. Parrish is also a trustee of Lawrence University and a member of the President’s Advisory Council. From 1977 until 1986, Mr. Parrish was the President of the Global Pharmaceutical Group of G.D. Searle & Co. (“Searle”), a pharmaceutical/consumer products company. From 1974 until 1977, Mr. Parrish was the President of Searle International, the foreign sales operation of Searle. Prior to that, Mr. Parrish was Executive Vice President of Pfizer’s International Division.

Basic Compensation

Total Annual Compensation, USD 169,908
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 13,052
Fiscal Year Total, USD 182,960

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --